Can eicosapentaenoic acid maintain the original ribavirin dose or affect the response during the treatment course of chronic hepatitis C virus (HCV) patients?
Abstract Background/Aims: Combination therapy with peginterferon (PEG-IFN) and ribavirin (RBV) has been recommended as a standard therapy for patients with chronic hepatitis C virus (HCV). Our aim was to evaluate the efficacy of eicosapentaenoic acid (EPA) against RBV-associated hemolytic anemia. Ma...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Turkish Society of Gastroenterology
2016-01-01
|
| coleção: | The Turkish Journal of Gastroenterology |
| Assuntos: | |
| Acesso em linha: | https://turkjgastroenterol.org/index.php/tjg/article/view/2836 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|